ArcherDx Inc (ArcherDx), a subsidiary of Integrated DNA Technologies Inc, is a genomic analysis company. It offers next-generation sequencing (NGS) technology for detecting variants associated with cancer, auto-immune and other genetic diseases. The company’s research products include solid tumor research products, blood cancer research products, custom panels and clinical research products. ArcherDx solid tumor research panels enable biomarker detection from both liquid and tissue biopsies. The company’s blood cancer research panels detect various mutations in hematologic malignancies such as myeloid and lymphoid diseases targeted by next-generation sequencing (NGS). Its brands include Archer, Anchored Multiplex, FusionPlex and VariantPlex. ArcherDx is headquartered in Boulder, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ArcherDx Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- ArcherDx Inc Company Overview
- ArcherDx Inc Company Snapshot
- ArcherDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- ArcherDx Inc - Pipeline Analysis Overview
- ArcherDx Inc - Key Facts
- ArcherDx Inc - Major Products and Services
- ArcherDx Inc Pipeline Products by Development Stage
- ArcherDx Inc Pipeline Products Overview
- AMP-Based Assay - Cancer
- AMP-Based Assay - Cancer Product Overview
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma Product Overview
- FusionPlex Dx
- FusionPlex Dx Product Overview
- LiquidPlex Dx
- LiquidPlex Dx Product Overview
- NextSeq 550Dx System - Blood Cancer CDx Assay
- NextSeq 550Dx System - Blood Cancer CDx Assay Product Overview
- NextSeq 550Dx System - Minimal Residual Disease Assay
- NextSeq 550Dx System - Minimal Residual Disease Assay Product Overview
- NextSeq 550Dx System - Solid Tumor CDx Assay
- NextSeq 550Dx System - Solid Tumor CDx Assay Product Overview
- NGS-Based Companion Diagnostic Assay - Cancer
- NGS-Based Companion Diagnostic Assay - Cancer Product Overview
- Pan-Notch Companion Diagnostic Assay
- Pan-Notch Companion Diagnostic Assay Product Overview
- PCM Liquid Biopsy - Non-Small Cell Lung Cancer
- PCM Liquid Biopsy - Non-Small Cell Lung Cancer Product Overview
- Stratafide Pan-Solid Tumor Companion Diagnostic Test
- Stratafide Pan-Solid Tumor Companion Diagnostic Test Product Overview
- ArcherDx Inc - Key Competitors
- ArcherDx Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ArcherDx Inc, Recent Developments
- Apr 14, 2023: Integrated DNA Technologies launches New Archer FUSIONPlex Core Solid Tumor Panel for Cancer Research
- Feb 17, 2022: Invitae introduces two IVD test kits for cancer in Europe
- Oct 05, 2020: Hematogenix unites with 19 organizations from the healthcare community to form COVID-19 testing industry consortium
- Oct 01, 2020: 19 Organizations from the healthcare community unite to form COVID-19 testing Industry Consortium
- Aug 03, 2020: ArcherDX and UCL Extend TRACERx Program Collaboration to Evaluate Cancer Evolution
- Jun 18, 2020: ArcherDX enters collaboration with Bristol Myers Squibb to apply Personalized Cancer Monitoring (PCM) to clinical research
- May 26, 2020: AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
- May 19, 2020: ArcherDX receives breakthrough device designation to detect NTRK gene fusions
- Apr 21, 2020: ArcherDX and Premier partner to deliver personalized genomic testing to patients
- Apr 15, 2020: Natera asserts three new oncology patents against ArcherDX
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ArcherDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- ArcherDx Inc Pipeline Products by Equipment Type
- ArcherDx Inc Pipeline Products by Indication
- ArcherDx Inc, Key Facts
- ArcherDx Inc, Major Products and Services
- ArcherDx Inc Number of Pipeline Products by Development Stage
- ArcherDx Inc Pipeline Products Summary by Development Stage
- AMP-Based Assay - Cancer - Product Status
- AMP-Based Assay - Cancer - Product Description
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma - Product Status
- Companion Diagnostic Test - Diffuse Large B Cell Lymphoma - Product Description
- FusionPlex Dx - Product Status
- FusionPlex Dx - Product Description
- LiquidPlex Dx - Product Status
- LiquidPlex Dx - Product Description
- NextSeq 550Dx System - Blood Cancer CDx Assay - Product Status
- NextSeq 550Dx System - Blood Cancer CDx Assay - Product Description
- NextSeq 550Dx System - Minimal Residual Disease Assay - Product Status
- NextSeq 550Dx System - Minimal Residual Disease Assay - Product Description
- NextSeq 550Dx System - Solid Tumor CDx Assay - Product Status
- NextSeq 550Dx System - Solid Tumor CDx Assay - Product Description
- NGS-Based Companion Diagnostic Assay - Cancer - Product Status
- NGS-Based Companion Diagnostic Assay - Cancer - Product Description
- Pan-Notch Companion Diagnostic Assay - Product Status
- Pan-Notch Companion Diagnostic Assay - Product Description
- PCM Liquid Biopsy - Non-Small Cell Lung Cancer - Product Status
- PCM Liquid Biopsy - Non-Small Cell Lung Cancer - Product Description
- Stratafide Pan-Solid Tumor Companion Diagnostic Test - Product Status
- Stratafide Pan-Solid Tumor Companion Diagnostic Test - Product Description
- ArcherDx Inc, Subsidiaries
- Glossary
- ArcherDx Inc Pipeline Products by Equipment Type
- ArcherDx Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Genentech, Inc.
- Freenome Inc
- Grail LLC
- Ambry Genetics Laboratory
- GeneDX LLC
